Aptuit
Website: www.aptuit.com

Aptuit's SSCI division provides specialized services in the areas of solubility, dissolution, polymorphism, crystallization, solid-state problem solving and stability. We focus on improving and protecting API, formulated product, and the corresponding intellectual property for our customers. Working closely with our API business, as well as our formulation and preclinical technology services, we are able to use our solid-state expertise to add value throughout the entire drug development process.

O’Brien Jones, PLLC
Website: www.obrienjones.com

O’Brien Jones, PLLC is an intellectual property firm located in Tysons Corner, Virginia, in the Washington, DC metropolitan area. With degrees in biochemistry, chemistry, chemical engineering, electrical engineering, and mechanical engineering, we counsel clients in many different industries regarding a diverse array of technologies. We offer a wide range of services, including:

• Domestic and international patent preparation and prosecution
• Patent reissue and reexamination proceedings
• Strategic patent portfolio management
• Freedom-to-operate searches and reports
• Patentability, validity, enforceability, and infringement opinions

Bend Research Inc.
Website: www.bendresearch.com

Bend Research Inc. specializes in the invention, advancement, development, and commercialization of pharmaceutical and health science technologies. We develop drug-delivery solutions from a base of fundamental understanding, provide formulation and dosage-form assistance, and advance drug candidates all the way to commercialization. We have a number of proprietary platform technologies available for licensing, including our spray-dried dispersion (SDD) technology that increases the bioavailability of low-solubility compounds. At Bend Research, we seek to develop strong alliances with companies that have challenging drug-delivery problems to solve. Please call Bruce Johnson at 541-382-4100 to learn more about our research, development, and GMP manufacturing capabilities.

Catalent Pharma Solutions
Website: www.catalent.com

Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies as well as development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health companies. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent’s proprietary drug delivery and packaging technologies enable customers to achieve their desired clinical and market outcomes, and are used in many well-known products. With experience in more than 100 countries and a global facility network that spans five continents, Catalent is well positioned to serve you, wherever you do business

Croda Inc
Website: www.croda.com/healthcare

Croda Inc manufactures a variety of excipients using several technologies such as molecular distillation, esterification, ethoxylation, and fractionation. In addition, Croda provides a line of Super Refined excipients produced using a proprietary process that removes polar and oxidative impurities, resulting in high-purity products that provide enhanced stability to the final dosage form.

CyDex Pharmaceuticals
Website: www.cydexpharma.com

CyDex Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of drugs specifically designed to address limitations of current therapies in selected established markets. We have developed a portfolio of product candidates utilizing our drug formulation technology using Captisol® cyclodextrins. Captisol® cyclodextrins are a patent protected, specifically modified family of cyclodextrins designed to improve solubility, stability, bioavailability, safety and/or dosing of a number of active pharmaceutical ingredients, or APIs.

Eurand
Website: www.Eurand.com

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. The Company's technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking, orally disintegrating tablet (ODT) formulations, and drug conjugation.

ISP Pharmaceuticals
Website: www.isppharmaceuticals.com

ISP Pharmaceuticals is a global business providing products and services for drug synthesis, drug solubilization, excipients and coatings. Built on a foundation of science, our excipient portfolio includes Plasdone® binders and Polyplasdone® disintegrants. ISP offers contract manufacturing services of APIs and intermediates. With expertise in material science, ISP provides both ingredients and process technology services to improve drug solubility. We have expertise in cGMP spray-dried solid dispersions for bioavailability enhancement and provide development, clinical supply and commercial manufacturing services. With experience working with more than 100 actives in last 2 years, we can assist with your drug solubility challenges.

Xspray
Website: www.xspray.com

XSpray Microparticles AB is a Swedish life science technology company with in-depth knowledge of supercritical fluid technology, solid state properties, formulation science and the drug development process. The Company’s RightSize™ Particle Manufacture – uses supercritical fluid as an antisolvent for controlled precipitation of an active pharmaceutical ingredient/drug substance. A key advantage of RightSize Particle Manufacture is that it can be effectively scaled up to production volumes, making it an important breakthrough in the manufacture of pharmaceutical particles. The process yields consistent powder particles in terms of size, shape and morphology that simplify formulation. RightSize technology enables development of drugs with low solubility.